| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/02/2023 | 38.71% | HC Wainwright & Co. | $8 → $11 | Maintains | Buy |
| 06/21/2023 | 0.88% | HC Wainwright & Co. | $9.5 → $8 | Maintains | Buy |
| 05/03/2023 | 19.8% | HC Wainwright & Co. | $8 → $9.5 | Maintains | Buy |
| 03/02/2023 | 0.88% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 10/13/2022 | -11.73% | Mizuho | → $7 | Initiates Coverage On | → Buy |
| 09/07/2022 | 0.88% | HC Wainwright & Co. | $8.5 → $8 | Maintains | Buy |
| 09/14/2021 | 7.19% | HC Wainwright & Co. | $20 → $8.5 | Maintains | Buy |
| 07/26/2021 | 190.04% | Northland Capital Markets | → $23 | Initiates Coverage On | → Outperform |
| 03/19/2021 | 152.21% | HC Wainwright & Co. | → $20 | Initiates Coverage On | → Buy |
What is the target price for MiMedx Group (MDXG)?
The latest price target for MiMedx Group (NASDAQ: MDXG) was reported by HC Wainwright & Co. on August 2, 2023. The analyst firm set a price target for $11.00 expecting MDXG to rise to within 12 months (a possible 38.71% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MiMedx Group (MDXG)?
The latest analyst rating for MiMedx Group (NASDAQ: MDXG) was provided by HC Wainwright & Co., and MiMedx Group maintained their buy rating.
When is the next analyst rating going to be posted or updated for MiMedx Group (MDXG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MiMedx Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MiMedx Group was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.
Is the Analyst Rating MiMedx Group (MDXG) correct?
While ratings are subjective and will change, the latest MiMedx Group (MDXG) rating was a maintained with a price target of $8.00 to $11.00. The current price MiMedx Group (MDXG) is trading at is $7.93, which is out of the analyst's predicted range.